Sales Contact
T: +33 1 4770 3024
Email
Industry Publications

"Long Term Care for the Elderly in France, European Comparison", 2011

Industry Report published by Candesic, Deomenos and Epsilon Research

Click here for preview

 

> Order an Epsilon Market Report (starting at €950) > mail

NB: includes access to the underlying EMAT reports

Alert on Reports Published
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

Subscribe

Follow the sector on Twitter

Epsilon Research covers the M&A transactions for the "Health, Pharmaceuticals & Biotechnology" industry [894 EMAT Reports], which includes:

 

Our analysts publish transaction multiples reports for private company M&A deals (announced 2004 onwards).

Each report presents detailed information on the deal value, structure and rationale, the target's activity, history and financial information; it includes the calculation of the key historic and current multiples: enterprise value over sales (EV/S), EBITDA (EV/EBITDA), or EBIT (EV/EBIT), P/E and Price to Book. All information sources are systematically given and company financials are carefully verified and restated if needed.

 

The reports are a unique source of information to have a comparable metric for the valuation of a private company, establish the "market value" of an investment or private equity investment portfolios.

 

The deal reports are published in Epsilon's EMAT database.
For an example of EMAT report, please click on this link.
If you wish to buy an EMAT Report, and you are not a customer, please contact us.

 

Recent M&A Deal Reports Published on EMAT

Date Acquirer Target Country Industries Valuation multiples See details
19/12/2018 ATS Automation Tooling Systems Comecer Italy Medical Equipment ** 92686
26/11/2018 AddLife BIOMEDICA Medizinprodukte Austria Medical Equipment ** 92884
08/11/2018 Aphria CC Pharma Germany Drugs Retailers, Pharmaceuticals ** 92067
04/09/2018 Cattleya Finance Parfums Caron Paris Personal Products ** 93591
21/08/2018 Vivalto Sante Capio Gestion Rhône Clinics and hospitals *** 90851
01/08/2018 Groupe C2S Clinique Saint-Martin Haute-Savoie Clinics and hospitals ** 93561
29/06/2018 Private Group led by MBO Partneraires Laboratoires Embryolisse Hauts-De-Seine Personal Products * 90252
29/06/2018 Private Group led by CVC, PSP Investments and StepStone Recordati Italy Pharmaceuticals, Biomedical Research Laboratory *** 90264
14/06/2018 Financing round led by Extendam and Rives Croissance Absolution Paris Personal Products *** 92461
20/04/2018 Private Group Led by Axcel Management Orion Diagnostica Finland Diagnostic Medical Equipment * 89193
03/04/2018 Fagron Humco Texas Pharmaceuticals, Biomedical Research Laboratory ** 90095
12/03/2018 Private Group led by Adolfsen Group Frösunda Omsorg Sweden Care Home, Specialist Care ** 88688
08/03/2018 Private Group led by the Management O₂ Développement (Oui care) Sarthe Home Care, Home Help Services * 93310
25/01/2018 Dechra Pharmaceuticals AST Farma & Le Vet Beheer Netherlands Veterinary Pharmaceuticals ** 88864
17/01/2018 Private Group led by Eurazeo Groupe C2S Loire Clinics and hospitals * 90832
09/01/2018 Elivie Horus Santé Vaucluse Home Care ** 94014
02/01/2018 La Phocéenne de Cosmétique (Le Petit Olivier) Biocos Marketing Développement (Lovea) Isère Personal Products * 88075
01/01/2018 Bastide Le Confort Médical (BLCM) Groupe Services Oxygène Bouches-Du-Rhône Home Care ** 93969
08/12/2017 Medtronic Crospon Ireland Diagnostic Medical Equipment * 88215
08/11/2017 Private Group Led by Fremont Realty Capital Porthaven Group United Kingdom Care Home * 88720
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Database
Epsilon Multiple Analysis Tool
The Reference Source for Private Company Acquisition Multiples

Test & Subscribe
EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report